SPONSOR
The Third People's Hospital of Chengdu
Total Trials
1
Recruiting
1
Phases
N/A
Conditions studied: Fatty Liver Disease
The Third People's Hospital of Chengdu is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Fatty Liver Disease.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — The Third People's Hospital of Chengdu
How many clinical trials has The Third People's Hospital of Chengdu sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by The Third People's Hospital of Chengdu, of which 1 are actively recruiting participants. These trials cover conditions including Fatty Liver Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does The Third People's Hospital of Chengdu research focus on?
The Third People's Hospital of Chengdu clinical trials span Fatty Liver Disease. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a The Third People's Hospital of Chengdu clinical trial?
To participate in a The Third People's Hospital of Chengdu trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all The Third People's Hospital of Chengdu trials with current recruitment status updated daily.
Clinical Trials by The Third People's Hospital of Chengdu
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology